Product information and disease descriptionProduct descriptionProduct information
Access and distribution
2 evidence topics · 1 source
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionProduct descriptionProduct information
2 evidence topics · 1 source